Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial's eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 1 - 20 of 33 trials
Titlesort icon Investigator Disease(s)
A Phase I Study of AM0010 in Patients with Advanced Solid Tumors
[Protocol 13-224]
Autio, Karen
  • Colorectal Cancer
  • Hepatobiliary
    • Pancreatic Cancer
  • Kidney Cancer
  • Lung Cancer
  • Melanoma
  • Ovarian Cancer
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
  • Upper Gastrointestinal
    • Pancreatic Cancer
A Phase I Study of BKM120 and Olaparib in Patients with High-Grade Serous Ovarian Cancer
[Protocol 12-233]
Bell-McGuinn, Katherine
  • Breast Cancer
  • Ovarian Cancer
A Phase I Study of Carboplatin/Paclitaxel/Bevacizumab and ABT-888 in Patients with Previously Untreated Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 09-106]
Bell-McGuinn, Katherine
  • Ovarian Cancer
A Phase I Study of DLYE5953A in Patients with Advanced or Persistent Solid Tumors
[Protocol 14-089]
Modi, Shanu
  • Breast Cancer
  • Head & Neck Cancer
  • Hepatobiliary
    • Pancreatic Cancer
  • Lung Cancer, Non-Small Cell
  • Ovarian Cancer
  • Upper Gastrointestinal
    • Gastric Cancer
    • Pancreatic Cancer
A Phase I Study of Lirilumab plus Nivolumab in Patients with Advanced Solid Tumors
[Protocol 12-224]
Segal, Neil
  • Colorectal Cancer
  • Kidney Cancer
  • Lung Cancer, Non-Small Cell
  • Melanoma
  • Ovarian Cancer
A Phase I Study of Lurbinectedin plus Paclitaxel in Patients with Advanced Solid Tumors
[Protocol 13-170]
Drilon, Alexander
  • Breast Cancer
  • Cervical Cancer
  • Germ Cell Tumors
  • Head & Neck Cancer
  • Lung Cancer
  • Ovarian Cancer
  • Solid Tumors
  • Uterine (Endometrial) Cancer
A Phase I Study of MEDI4736 in Patients with Advanced Solid Tumors
[Protocol 13-198]
Callahan, Margaret
  • Cervical Cancer
  • Colorectal Cancer
  • Head & Neck Cancer
  • Kidney Cancer
  • Lung Cancer, Non-Small Cell
  • Ovarian Cancer
  • Solid Tumors
A Phase I Study of Selinexor (KPT-330) with Paclitaxel and Carboplatin for Treating Advanced Ovarian and Endometrial Cancers
[Protocol 14-110]
Makker, Vicky
  • Ovarian Cancer
  • Uterine (Endometrial) Cancer
  • Uterine Sarcoma
    • Carcinosarcoma
A Phase I Study of STM 434 in Patients with Ovarian Cancer and Other Advanced Solid Tumors
[Protocol 14-132]
Hyman, David
  • Ovarian Cancer
  • Solid Tumors
A Phase IA/IB Study of RO5509554 Alone and with Paclitaxel in Patients with Advanced Solid Tumors
[Protocol 14-086]
D'Angelo, Sandra
  • Breast Cancer
  • Endometrial and other Uterine Cancers
    • Endometrial Cancer
  • Hepatobiliary
    • Pancreatic Cancer
  • Mesothelioma
  • Ovarian Cancer
  • Sarcomas
    • Soft Tissue Sarcoma
  • Solid Tumors
  • Upper Gastrointestinal
    • Pancreatic Cancer
A Phase IB Study of MEK162 plus Paclitaxel in Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 12-192]
Grisham, Rachel
  • Ovarian Cancer
A Phase Ib Study of OMP-54F28 with Paclitaxel and Carboplatin in Patients with Recurrent Platinum-Sensitive Ovarian Cancer
[Protocol 14-029]
O'Cearbhaill, Roisin
  • Ovarian Cancer
A Phase II Study of BYL719 plus AMG 479 (Ganitumab) in Patients with Advanced Ovarian Cancer or Hormone Receptor-Positive Breast Cancer
[Protocol 13-251]
Modi, Shanu
  • Breast Cancer
  • Ovarian Cancer
A Phase II Study of Dalantercept for Treating Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 13-109]
Makker, Vicky
  • Ovarian Cancer
A Phase II Study of Dasatinib to Treat Recurrent Clear Cell Cancer of the Ovaries or Endometrium
[Protocol 14-008]
Hyman, David
  • Ovarian Cancer
  • Uterine (Endometrial) Cancer
A Phase II Study of Enzalutamide in Patients with Advanced or Recurrent Androgen Receptor-Positive Ovarian Cancer
[Protocol 13-119]
Grisham, Rachel
  • Ovarian Cancer
A Phase II Study of Neratinib in Patients with Solid Tumors Containing Mutated HER2
[Protocol 13-140]
Hyman, David
  • Bladder Cancer
  • Colorectal Cancer
  • Ovarian Cancer
  • Solid Tumors
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer
  • Uterine (Endometrial) Cancer
A Phase II Study of Paclitaxel/Carboplatin versus Bleomycin/Etoposide/Cisplatin for Patients with Advanced Ovarian Stromal Tumors Who Have Not Received Chemotherapy
Relapsed/Refractory
[Protocol 13-177]
Leitao, Mario
  • Ovarian Cancer
A Phase II Study of Pimasertib with SAR245409 or a Placebo in Women with Previously Treated Inoperable Low-Grade Ovarian Cancer
[Protocol 13-173]
Grisham, Rachel
  • Ovarian Cancer
A Phase II Study of Rucaparib in Patients Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Relapsed/Refractory
[Protocol 13-255]
Bell-McGuinn, Katherine
  • Ovarian Cancer